← Insider buys
RVNC

Revance Therapeutics, Inc.

CFO, CBO, Secretary Lauren P Silvernail sold $640K of Revance Therapeutics, Inc.

Sold$640,000
$32.00Price
20,000Shares
−22%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Wed, Mar 7. Filed Fri, Mar 9, 3:34 PM ET, during the session. Not investment advice.